Exploring the in vitro anti-inflammatory activity of gross saponins of Tribulus terrestris L. fruit by using liquid chromatography-mass spectrometry-based cell metabolomics approach.

Tribulus terrestris L cell metabolomics liquid chromatography-mass spectrometry signaling pathway traditional Chinese medicine

Journal

Journal of separation science
ISSN: 1615-9314
Titre abrégé: J Sep Sci
Pays: Germany
ID NLM: 101088554

Informations de publication

Date de publication:
07 Nov 2023
Historique:
revised: 01 10 2023
received: 26 07 2023
accepted: 01 10 2023
medline: 7 11 2023
pubmed: 7 11 2023
entrez: 7 11 2023
Statut: aheadofprint

Résumé

Our previous studies confirmed the efficacy of gross saponins of Tribulus terrestris L. fruit in treating cerebral ischemia. This study aimed to investigate the related mechanisms in vitro. The lipopolysaccharide-induced BV2 cells model was constructed and treated with gross saponins at different concentrations to explore its anti-inflammatory activity. The cell metabolite changes were tracked by liquid chromatography-mass spectrometry (LC-MS)-based metabolomics, and the metabolic biomarkers and related metabolic pathways were analyzed. Molecular biochemistry analysis was further used to verify the relevant inflammatory pathways. The results showed that the saponins reduced nitric oxide release and the secretion of tumor necrosis factor-alpha, interleukin-1β, and interleukin-6 from lipopolysaccharide-induced BV2 cells. Metabolic perturbations occurred in lipopolysaccharide-treated BV2 cells, which could be reversed by drug treatment via mainly regulating glycerophospholipid metabolism, tryptophan metabolism, purine metabolism pathways, etc. The western blot analysis demonstrated that saponin could suppress the activation of the inflammatory-related signaling pathway. The present study explored the in vitro anti-inflammatory mechanism of gross saponins of Tribulus terrestris L. fruit using an LC-MS-based cell metabolomics approach, which confirms the great potential of LC-MS for drug efficacy evaluation and can be applied in other herbal medicine-related analyses.

Identifiants

pubmed: 37933967
doi: 10.1002/jssc.202300531
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300531

Subventions

Organisme : National Natural Science Foundation of China
ID : 82104366
Organisme : National Natural Science Foundation of China
ID : 81573590

Informations de copyright

© 2023 Wiley-VCH GmbH.

Références

Bhatt N, Malik AM, Chaturvedi S. Stroke in young adults: five new things. Neurol Clin Pract. 2018;8:501-506.
Qin X, Akter F, Qin L, Cheng J, Guo M, Yao S, et al. Adaptive immunity regulation and cerebral ischemia. Front Immunol. 2020;11:689.
Anthony S, Cabantan D, Monsour M, Borlongan CV. Neuroinflammation, stem cells, and stroke. Stroke 2022;53:1460-1472.
Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130:2777-2788.
Kong L, Li W, Chang E, Wang W, Shen N, Xu X, et al. mtDNA-STING axis mediates microglial polarization via IRF3/NF-kappaB signaling after ischemic stroke. Front Immunol. 2022;13:860977.
Xu S, Lu J, Shao A, Zhang JH, Zhang J. Glial cells: role of the immune response in ischemic stroke. Front Immunol. 2020;11:294.
Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. 2020;21:6454.
DeLong JH, Ohashi SN, O'Connor KC, Sansing LH. Inflammatory responses after ischemic stroke. Semin Immunopathol. 2022;44:625-648.
Huang S, Liu L, Tang X, Xie S, Li X, Kang X, et al. Research progress on the role of hormones in ischemic stroke. Front Immunol. 2022;13:1062977.
Guo S, Geng X, Lee H, Ding Y. Phenothiazine Inhibits neuroinflammation and inflammasome activation independent of hypothermia after ischemic stroke. Mol Neurobiol. 2021;58:6136-6152.
Nakamura A, Otani K, Shichita T. Lipid mediators and sterile inflammation in ischemic stroke. Int Immunol. 2020;32:719-725.
Jiang YH, Guo JH, Wu S, Yang CH. Vascular protective effects of aqueous extracts of Tribulus terrestris on hypertensive endothelial injury. Chin J Nat Med. 2017;15:606-614.
Saleem U, Chauhdary Z, Raza Z, Shah S, Rahman MU, Zaib P, et al. Anti-Parkinson's activity of Tribulus terrestris via modulation of AChE, α-synuclein, TNF-α, and IL-1β. ACS Omega. 2020;5:25216-25227.
Zhang H, Guo W, Li X, Xie S, Liu Y, Chen G, et al. Supplementation with Tribulus terrestris extract exhibits protective Effects on MCAO Rats via modulating Inflammation-related metabolic and signaling pathways. ACS Omega. 2023;8:2306-2314.
Tian C, Chang Y, Liu X, Zhang Z, Guo Y, Lan Z, et al. Anti-inflammatory activity in vitro, extractive process and HPLC-MS characterization of total saponins extract from Tribulus terrestris L. fruits. Ind Crops Prod. 2020;150:112343.
Guo W, Wang Y, Fan M, Xie S, Zhao H, Wang J, et al. Integrating metabolomics and network pharmacology to explore the protective effect of gross saponins of Tribulus terrestris L. fruit against ischemic stroke in rat. J Ethnopharmacol. 2020;263:113202.
Li X, Guo W, Zhao L, Xu D, Xu X, Han Y, et al. Investigating the in vivo effect of Tribulus terrestris extract in middle cerebral artery occlusion rats using LC-MS-based metabolomics combined with molecular docking. Biomed Chromatogr. 2023;37:e5614.
Wang Y, Guo W, Liu Y, Wang J, Fan M, Zhao H, et al. Investigating the protective effect of gross saponins of Tribulus terrestris fruit against ischemic stroke in rat using metabolomics and network pharmacology. Metabolites 2019;9:240.
Wang Y, Guo W, Xie S, Liu Y, Xu D, Chen G, et al. Multi-omics analysis of brain tissue metabolome and proteome reveals the protective effect of gross saponins of Tribulus terrestris L. fruit against ischemic stroke in rat. J Ethnopharmacol. 2021;278:114280.
Wang Y, Zhao H, Liu Y, Guo W, Bao Y, Zhang M, et al. GC-MS-based metabolomics to reveal the protective effect of gross saponins of Tribulus terrestris fruit against ischemic stroke in rat. Molecules 2019;24:793.
Xu D, Wang Y, Guo W, Li X, Liu Y, Han Y, et al. LC-MS-based multi-omics analysis of brain tissue for the evaluation of the anti-ischemic stroke potential of Tribulus terrestris L. fruit extract in MCAO rats. Arab J Chem. 2022;15:104297.
Chiocchio I, Prata C, Mandrone M, Ricciardiello F, Marrazzo P, Tomasi P, et al. Leaves and spiny burs of castanea sativa from an experimental chestnut grove: metabolomic analysis and anti-neuroinflammatory activity. Metabolites 2020;10:408.
Chen Y, Sun JX, Chen WK, Wu GC, Wang YQ, Zhu KY, et al. miR-124/VAMP3 is a novel therapeutic target for mitigation of surgical trauma-induced microglial activation. Signal Transduct Target Ther. 2019;4:27.
Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol. 2019;94:112-120.
Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009;26:83-94.
Lu Q, Zhang J, Xin L, Lou Y, Qin F, Zhao L, et al. Integrated gas chromatography-mass spectrometry and ultra-high-performance liquid chromatography-mass spectrometry renal metabolomics and lipidomics deciphered the metabolic regulation mechanism of Gushudan on kidney-yang-deficiency-syndrome rats. J Sep Sci. 2023;46:2300124.
Yang N, Hu W, He J, Wu X, Zou T, Zheng J, et al. Ultra-high performance liquid chromatography-quadrupole/time-of-flight mass spectrometry-based lipidomics reveals key lipid molecules as potential therapeutic targets of Polygonum cuspidatum against hyperlipidemia in a hamster model. J Sep Sci. 2023;46:2200844.
Wang Y, Liu S, Hu Y, Li P, Wan J-B. Current state of the art of mass spectrometry-based metabolomics studies-a review focusing on wide coverage, high throughput and easy identification. RSC Adv. 2015;5:78728-78737.
Takeda H, Yamaguchi T, Yano H, Tanaka J. Microglial metabolic disturbances and neuroinflammation in cerebral infarction. J Pharmacol Sci. 2021;145:130-139.
Zhao M, Yao Y, Du J, Kong L, Zhao T, Wu D, et al. 6-Gingerol alleviates neonatal hypoxic-ischemic cerebral and white matter injury and contributes to functional recovery. Front Pharmacol. 2021;12:707772.
Nicolas GR, Chang PV. Deciphering the chemical lexicon of host-gut microbiota interactions. Trends Pharmacol Sci. 2019;40:430-445.
Gutiérrez-Vázquez C, Quintana FJ. Regulation of the immune response by the Aryl hydrocarbon receptor. Immunity. 2018;48:19-33.
Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294.
Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22:586-597.
Sun J, Zhang Y, Kong Y, Ye T, Yu Q, Kumaran Satyanarayanan S, et al. Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice. Brain Behav Immun. 2022;106:76-88.
Koberlin MS, Snijder B, Heinz LX, Baumann CL, Fauster A, Vladimer GI, et al. A conserved circular network of coregulated lipids modulates innate immune responses. Cell 2015;162:170-183.
Puig B, Altmeppen HC, Linsenmeier L, Chakroun K, Wegwitz F, Piontek UK, et al. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLoS Pathog. 2019;15:e1007520.
Szeto HH, Liu S. Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging. Arch Biochem Biophys. 2018;660:137-148.
Magalhaes JD, Cardoso SM. Mitochondrial signaling on innate immunity activation in Parkinson disease. Curr Opin Neurobiol. 2023;78:102664.

Auteurs

Xiaohang Xu (X)

School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, China.
Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Wenjun Guo (W)

School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, China.

Liang Zhao (L)

Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Yuanhe Sun (Y)

School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, China.

Dandan Xu (D)

Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Jingxuan Yang (J)

School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, China.

Yue Liu (Y)

Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Shengxu Xie (S)

Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Yang Wang (Y)

Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.

Yajuan Xu (Y)

Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Classifications MeSH